These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 31950403)
1. Recognition and Treatment of Homozygous Familial Hypercholesterolemia by Primary Care Physicians: a Survey from the National Lipid Association. Hemphill L; Goldberg A; Hovingh K; Cohen J; Karalis DG J Gen Intern Med; 2020 Jul; 35(7):2225-2227. PubMed ID: 31950403 [No Abstract] [Full Text] [Related]
2. Managing the challenging homozygous familial hypercholesterolemia patient: Academic insights and practical approaches for a severe dyslipidemia, a National Lipid Association Masters Summit. Hovingh GK; Goldberg AC; Moriarty PM J Clin Lipidol; 2017; 11(3):602-616. PubMed ID: 28506384 [TBL] [Abstract][Full Text] [Related]
3. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship. Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735 [TBL] [Abstract][Full Text] [Related]
4. Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. Hopkins PN; Toth PP; Ballantyne CM; Rader DJ; J Clin Lipidol; 2011 Jun; 5(3 Suppl):S9-17. PubMed ID: 21600530 [No Abstract] [Full Text] [Related]
5. Phenotypical, Clinical, and Molecular Aspects of Adults and Children With Homozygous Familial Hypercholesterolemia in Iberoamerica. Alves AC; Alonso R; Diaz-Diaz JL; Medeiros AM; Jannes CE; Merchan A; Vasques-Cardenas NA; Cuevas A; Chacra AP; Krieger JE; Arroyo R; Arrieta F; Schreier L; Corral P; Bañares VG; Araujo MB; Bustos P; Asenjo S; Stoll M; Dell'Oca N; Reyes M; Ressia A; Campo R; Magaña-Torres MT; Metha R; Aguilar-Salinas CA; Ceballos-Macias JJ; Morales ÁJR; Mata P; Bourbon M; Santos RD Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2508-2515. PubMed ID: 32757650 [TBL] [Abstract][Full Text] [Related]
6. Case report-Rapid regression of xanthomas under lipoprotein apheresis in a boy with homozygous familial hypercholesterolemia. Katzmann J; Schürfeld C; März W; Laufs U J Clin Lipidol; 2018; 12(4):868-871. PubMed ID: 29866529 [TBL] [Abstract][Full Text] [Related]
8. Clinical features, diagnosis and frequency of familial hypercholesterolemia. Khachadurian AK Beitr Infusionsther; 1988; 23():26-32. PubMed ID: 2484779 [No Abstract] [Full Text] [Related]
9. Results and Lessons of a Pilot Study of Cascade Screening for Familial Hypercholesterolemia in US Primary Care Practices. Neuner J; Dimmock D; Kirschner AP; Beaudry H; Paradowski J; Orlando L J Gen Intern Med; 2020 Jan; 35(1):351-353. PubMed ID: 31667742 [No Abstract] [Full Text] [Related]
10. Role of LDL apheresis in a case of homozygous familial hypercholesterolemia. Naveen T; Biswas A; Wig N; Soneja M; Jorwal P; Durga CS; Singla P; Chaudhary C; Baitha U Drug Discov Ther; 2019; 13(1):59-61. PubMed ID: 30880324 [TBL] [Abstract][Full Text] [Related]
11. Collateral damage of the COVID-19 pandemic on the management of homozygous familial hypercholesterolemia. Kayikcioglu M; Tokgozoglu L; Tuncel OK; Pirildar S; Can L J Clin Lipidol; 2021; 15(2):381-382. PubMed ID: 34099193 [No Abstract] [Full Text] [Related]
13. [Homozygous familial hypercholesterolemia: development and a case illustration]. Choukri M; Laaroussi N; Taheri H; Chabraoui L Ann Biol Clin (Paris); 2013; 71(1):99-103. PubMed ID: 23396432 [TBL] [Abstract][Full Text] [Related]
14. What Is the Prevalence of Familial Hypercholesterolemia? Brunham LR; Hegele RA Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2629-2631. PubMed ID: 34433299 [No Abstract] [Full Text] [Related]
15. Editorial Commentary: What Determines the Risk of Cardiovascular Disease in Familial Hypercholesterolemia? Brunham LR; Mancini GBJ Trends Cardiovasc Med; 2021 May; 31(4):216-217. PubMed ID: 32407995 [No Abstract] [Full Text] [Related]
16. The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia. Drouin-Chartier JP; Tremblay AJ; Bergeron J; Lamarche B; Couture P Circulation; 2017 Aug; 136(9):880-882. PubMed ID: 28847800 [No Abstract] [Full Text] [Related]